Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Cervical Neoplasms | 40 | 2022 | 1962 | 7.720 |
Why?
|
Papillomavirus Infections | 36 | 2022 | 1470 | 7.520 |
Why?
|
Papillomavirus Vaccines | 24 | 2022 | 477 | 6.560 |
Why?
|
Papillomaviridae | 11 | 2022 | 1124 | 2.580 |
Why?
|
Early Detection of Cancer | 26 | 2022 | 2865 | 2.570 |
Why?
|
Cost-Benefit Analysis | 23 | 2022 | 5235 | 1.900 |
Why?
|
Human papillomavirus 18 | 6 | 2020 | 128 | 1.800 |
Why?
|
Vaccination | 17 | 2022 | 2864 | 1.770 |
Why?
|
Norway | 13 | 2021 | 456 | 1.460 |
Why?
|
Human papillomavirus 16 | 6 | 2020 | 262 | 1.260 |
Why?
|
Colposcopy | 5 | 2021 | 143 | 0.940 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2022 | 101 | 0.910 |
Why?
|
Vaginal Smears | 5 | 2022 | 498 | 0.900 |
Why?
|
Mass Vaccination | 2 | 2019 | 106 | 0.790 |
Why?
|
Mass Screening | 14 | 2022 | 5182 | 0.720 |
Why?
|
Cell Transformation, Viral | 1 | 2020 | 672 | 0.700 |
Why?
|
Immunization Schedule | 1 | 2018 | 216 | 0.630 |
Why?
|
Self-Examination | 1 | 2016 | 71 | 0.620 |
Why?
|
Tumor Virus Infections | 1 | 2018 | 453 | 0.570 |
Why?
|
Cervical Intraepithelial Neoplasia | 5 | 2020 | 315 | 0.570 |
Why?
|
Anus Neoplasms | 1 | 2018 | 293 | 0.540 |
Why?
|
Quality-Adjusted Life Years | 10 | 2022 | 1592 | 0.530 |
Why?
|
Models, Statistical | 7 | 2021 | 5034 | 0.520 |
Why?
|
Urogenital Neoplasms | 1 | 2014 | 140 | 0.460 |
Why?
|
Computer Simulation | 5 | 2020 | 6048 | 0.450 |
Why?
|
Intention | 1 | 2014 | 312 | 0.430 |
Why?
|
Health Care Costs | 5 | 2019 | 3152 | 0.400 |
Why?
|
Incidence | 11 | 2022 | 20320 | 0.370 |
Why?
|
Cost of Illness | 1 | 2019 | 1820 | 0.360 |
Why?
|
Patient Compliance | 2 | 2017 | 2758 | 0.360 |
Why?
|
Female | 48 | 2022 | 375205 | 0.360 |
Why?
|
Adult | 29 | 2021 | 211041 | 0.270 |
Why?
|
Uncertainty | 2 | 2021 | 642 | 0.270 |
Why?
|
Humans | 52 | 2022 | 708843 | 0.270 |
Why?
|
Alphapapillomavirus | 2 | 2018 | 220 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 2 | 2015 | 2927 | 0.240 |
Why?
|
Diabetic Retinopathy | 2 | 2022 | 1202 | 0.240 |
Why?
|
Healthcare Disparities | 3 | 2021 | 2996 | 0.230 |
Why?
|
Delivery of Health Care | 3 | 2022 | 4810 | 0.230 |
Why?
|
Age Factors | 4 | 2020 | 18712 | 0.230 |
Why?
|
Models, Economic | 4 | 2019 | 723 | 0.230 |
Why?
|
Age of Onset | 2 | 2020 | 3330 | 0.220 |
Why?
|
Vaccines, Combined | 1 | 2021 | 60 | 0.210 |
Why?
|
Cervix Uteri | 2 | 2022 | 575 | 0.210 |
Why?
|
Sensitivity and Specificity | 4 | 2020 | 14836 | 0.210 |
Why?
|
Middle Aged | 20 | 2021 | 213752 | 0.190 |
Why?
|
Anxiety | 1 | 2014 | 3887 | 0.190 |
Why?
|
Cytological Techniques | 1 | 2021 | 220 | 0.180 |
Why?
|
Neoplasms | 2 | 2019 | 20172 | 0.180 |
Why?
|
Policy | 1 | 2022 | 359 | 0.180 |
Why?
|
Models, Biological | 5 | 2020 | 9907 | 0.180 |
Why?
|
Time | 1 | 2020 | 526 | 0.170 |
Why?
|
Macular Edema | 1 | 2022 | 334 | 0.170 |
Why?
|
Geography | 1 | 2020 | 681 | 0.170 |
Why?
|
Sweden | 1 | 2020 | 1290 | 0.160 |
Why?
|
Developed Countries | 1 | 2020 | 402 | 0.160 |
Why?
|
Uganda | 2 | 2019 | 1097 | 0.160 |
Why?
|
Algorithms | 2 | 2017 | 13647 | 0.160 |
Why?
|
Models, Theoretical | 4 | 2017 | 3558 | 0.160 |
Why?
|
Adolescent | 10 | 2020 | 84718 | 0.160 |
Why?
|
Specimen Handling | 1 | 2021 | 693 | 0.150 |
Why?
|
Young Adult | 11 | 2020 | 55940 | 0.150 |
Why?
|
Immunity, Herd | 1 | 2016 | 42 | 0.150 |
Why?
|
Child | 9 | 2021 | 73636 | 0.150 |
Why?
|
Health Policy | 2 | 2019 | 2615 | 0.150 |
Why?
|
Calibration | 1 | 2018 | 802 | 0.150 |
Why?
|
Developing Countries | 4 | 2020 | 2674 | 0.140 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2016 | 126 | 0.140 |
Why?
|
Monte Carlo Method | 3 | 2015 | 1301 | 0.130 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5348 | 0.130 |
Why?
|
Epidemics | 1 | 2020 | 481 | 0.130 |
Why?
|
Hysterectomy | 1 | 2020 | 902 | 0.130 |
Why?
|
Genotype | 2 | 2020 | 12863 | 0.130 |
Why?
|
Decision Trees | 1 | 2015 | 521 | 0.120 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1110 | 0.120 |
Why?
|
Radiotherapy, Conformal | 1 | 2016 | 563 | 0.120 |
Why?
|
Practice Guidelines as Topic | 4 | 2018 | 7487 | 0.120 |
Why?
|
False Negative Reactions | 1 | 2014 | 610 | 0.120 |
Why?
|
HIV Infections | 1 | 2018 | 15538 | 0.120 |
Why?
|
CD4 Lymphocyte Count | 1 | 2018 | 2543 | 0.110 |
Why?
|
United States | 8 | 2021 | 67165 | 0.110 |
Why?
|
Aged | 12 | 2021 | 161488 | 0.110 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2016 | 440 | 0.110 |
Why?
|
School Health Services | 1 | 2015 | 378 | 0.110 |
Why?
|
Age Distribution | 1 | 2017 | 2876 | 0.110 |
Why?
|
Intravitreal Injections | 2 | 2022 | 317 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1418 | 0.100 |
Why?
|
Pandemics | 2 | 2021 | 7089 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 1435 | 0.100 |
Why?
|
Precancerous Conditions | 1 | 2017 | 964 | 0.100 |
Why?
|
DNA, Viral | 1 | 2017 | 2287 | 0.100 |
Why?
|
Forecasting | 1 | 2020 | 2941 | 0.100 |
Why?
|
Quality Improvement | 2 | 2016 | 3733 | 0.090 |
Why?
|
Male | 12 | 2022 | 349524 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2018 | 2029 | 0.080 |
Why?
|
Program Evaluation | 1 | 2016 | 2524 | 0.080 |
Why?
|
Income | 3 | 2020 | 1775 | 0.080 |
Why?
|
New Mexico | 2 | 2018 | 87 | 0.080 |
Why?
|
Biopsy | 1 | 2017 | 6766 | 0.070 |
Why?
|
Time Factors | 5 | 2018 | 41038 | 0.070 |
Why?
|
Risk | 1 | 2017 | 9641 | 0.070 |
Why?
|
Data Collection | 1 | 2014 | 3276 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2017 | 3436 | 0.060 |
Why?
|
Prevalence | 2 | 2018 | 14712 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13298 | 0.060 |
Why?
|
Pilot Projects | 1 | 2016 | 7994 | 0.060 |
Why?
|
Quality of Life | 2 | 2021 | 11594 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2018 | 4062 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19423 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3153 | 0.050 |
Why?
|
Parents | 1 | 2015 | 3154 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3275 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 3876 | 0.050 |
Why?
|
Logistic Models | 1 | 2014 | 13468 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39038 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6497 | 0.040 |
Why?
|
Lasers | 1 | 2022 | 945 | 0.040 |
Why?
|
Occult Blood | 1 | 2017 | 174 | 0.040 |
Why?
|
Risk Factors | 3 | 2018 | 69553 | 0.040 |
Why?
|
Registries | 3 | 2017 | 7989 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2017 | 1746 | 0.030 |
Why?
|
Models, Econometric | 1 | 2015 | 220 | 0.030 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2015 | 66 | 0.030 |
Why?
|
SEER Program | 1 | 2020 | 1549 | 0.030 |
Why?
|
Oral Surgical Procedures | 1 | 2016 | 162 | 0.030 |
Why?
|
Dexamethasone | 1 | 2022 | 1939 | 0.030 |
Why?
|
California | 1 | 2018 | 1392 | 0.030 |
Why?
|
Advisory Committees | 1 | 2018 | 759 | 0.030 |
Why?
|
World Health Organization | 1 | 2020 | 1261 | 0.030 |
Why?
|
Immunization Programs | 1 | 2015 | 277 | 0.030 |
Why?
|
Life Expectancy | 1 | 2018 | 1116 | 0.030 |
Why?
|
Radiotherapy | 1 | 2019 | 1623 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2022 | 2067 | 0.030 |
Why?
|
Feces | 1 | 2017 | 1365 | 0.030 |
Why?
|
Internationality | 1 | 2016 | 1002 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2016 | 1652 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2017 | 19800 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 4883 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3290 | 0.020 |
Why?
|
Triage | 1 | 2016 | 913 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2240 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2732 | 0.020 |
Why?
|
Poverty | 1 | 2019 | 2557 | 0.020 |
Why?
|
Mammography | 1 | 2017 | 2442 | 0.020 |
Why?
|
Social Class | 1 | 2015 | 1925 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2015 | 2315 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2021 | 4988 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2017 | 13536 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 61932 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15252 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 24433 | 0.010 |
Why?
|
Infant | 1 | 2020 | 34261 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 41081 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58184 | 0.010 |
Why?
|
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_